Kahn Brothers’ Top Stock Picks For Q3

Irving and Thomas Kahn are value investors who have been running their investment firm since 1978. Irving Kahn was one of legendary value investor Benjamin Graham’s students, and the firm’s emphasis on a stock’s pricing relative to its book value and historical earnings is much in line with that tradition. In early November Kahn Brothers filed its 13F for the third quarter of 2012, which discloses many of its long equity positions as of the end of September. Read on for our quick take on its top five holdings and compare their picks to previous filings.

Irving Kahn

The fund’s top pick was pharmaceutical manufacturer Pfizer Inc. (NYSE:PFE), with Kahn Brothers reporting a position of 2.5 million shares- essentially unchanged from three months earlier. The $184 billion market cap giant reported earnings growth of 25% in its most recent quarterly report compared to the same period in 2011 despite somewhat lower revenue. It trades at 18 times trailing earnings, but an optimistic analyst group projects continued strong growth that implies a forward P/E of only 11. With a 3.5% dividend yield as well, Pfizer’s got our attention; however, we’d need to do due diligence on that projected path to such an attractive P/E multiple. Billionaire Ken Fisher’s Fisher Asset Management has been another large investor in Pfizer.

New York Community Bancorp, Inc. (NYSE:NYB) was another of Kahn Brothers’ favorite stocks, though as with Pfizer the fund’s position was more or less unchanged at 3.6 million shares. The retail bank holding company trades at somewhat higher P/E and P/B multiples than many large banks- it is priced at 1.1 times the book value of its equity, and 12 times trailing earnings- but on an absolute basis New York Community Bancorp does not look particularly overpriced. The stock also offers a 7.2% dividend yield, having paid a 25 cent per share dividend every quarter since April 2004. Value investors should look at other banks, but income investors should take it into consideration.

Kahn Brothers’ position in Merck & Co., Inc. (NYSE:MRK) was also kept steady at 1.1 million shares. Like Pfizer, Merck is not a particularly good value stock when looking at trailing earnings- the P/E multiple is 21- but if Wall Street analysts are right then the company is in for some very good quarters that will bring its earnings up. That P/E becomes 12 on the basis of forward estimates. Merck’s dividend yield is also good, at 4.5%. As with Pfizer, we like that pricing as long as the company can deliver on those earnings targets- and would like to check the company out more closely.

The firm did slightly increase its stake in, of all things, The New York Times Company (NYSE:NYT), with the 4.7 million shares in its portfolio at the end of September being just a bit higher than the 4.6 million that it had owned three months earlier. The New York Times experienced a 16% decline in revenue in the third quarter of the year versus Q3 2011, which contributed to an 86% decrease in earnings over the same period. At 17 times consensus earnings for 2013- a figure which reflects a dramatic improvement in its business- we don’t think that investors should be buying.

Citigroup Inc. (NYSE:C) gave Kahn Brothers some exposure to the big banks in the second quarter, when the firm had bought the stock heavily, and it broke into the top five holdings in the 13F portfolio by the end of the third quarter. The megabank is getting a new CEO with the departure of Vikram Pandit, and is up 33% year to date. This has brought it to a multiple of 8 times expected earnings for next year, which we’d normally consider to be value territory, and it also trades at a steep discount to book value. We looked at Citi recently and decided that investors could buy it, JPMorgan Chase, or Wells Fargo depending on how much they valued low multiples versus safety and stability. Read our recent analysis of Citigroup.

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

7 Most Expensive Cities in the World

5 Least Expensive Cities in the World

10 Celebrities Who Believe In Scientology

10 High Margin Food Products to Build a Business Around

The 10 Most Expensive Clothing Stores in the United States to Get Decked Out At

The 5 Biggest Kickstarter Scams That Swindled Backers’ Donations

The 10 Most Expensive Boarding Schools In the World

50 Crazy Facts About Japan You Won’t Believe

Top 10 Least Expensive Hybrid Cars to Save the Planet With

The 10 Biggest ‘Gate’ Controversies in History

The 10 States with the Highest Nursing Shortages Leaving Their Hospitals Depleted

The 10 Best Value Investment Blogs that Every Investor Must Read

The 6 Cheapest Boarding Schools in Europe 2015

The 5 Most Expensive Cars To Insure in the World

The 10 Most Common Genetically Modified Foods

10 Self-Made Billionaires Who Came From Nothing

The 10 Most Expensive Cities to Live in North America

The 13 Most Expensive Headphones in the World to Represent

The Top 20 Wealthiest Soccer Teams in 2014

4 BuzzWorthy Cannabis Stocks And Some Smoking Derivative Plays

The 10 Healthiest Fast Food Chains in America to Dine At

The 5 Most Expensive Cat Food Brands You Can Spoil Your Kitty With

The 6 Best eCommerce Platforms for Small Businesses

The 10 Worst Mistakes an Entrepreneur Can Make

The 5 Most OP Characters in League of Legends to Carry Games and Crush Foes With

The 5 Best Foods to Eat Before Running that Will Help You Pound the Pavement

10 Glaring Plot Holes in The Walking Dead that a Zombie-Filled Bus Could Drive Through

The 5 Biggest Celebrity Stoners Who Love Their Reefer

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

Top 6 Cities For The Ultra Rich to Live in Comfort

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

How to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!